Britain has repeatedly trumpeted its mass vaccination programme against COVID-19, hailing its early approval of jabs as a key part of the long struggle to return to normal life. But infection rates remain stubbornly high, contrasting sharply with its European neighbours and prompting fresh questions of the government. For two weeks, the number of new